Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCT s-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCT s

Published:2018-09-09 Issue:2 Volume:139 Page:108-116
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Kubo K.¹,Fleischhacker W. W.¹²,Suzuki T.¹³^ORCID,Yasui‐Furukori N.⁴,Mimura M.¹,Uchida H.¹⁵^ORCID

Affiliation:

1. Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan

2. Department of Psychiatry, Psychotherapy and Psychosomatics Medical University Innsbruck Innsbruck Austria

3. Department of Neuropsychiatry and Clinical Ethics Faculty of Medicine University of Yamanashi Yamanashi Japan

4. Department of Neuropsychiatry Graduate School of Medicine Hirosaki University Hirosaki Japan

5. Geriatric Psychiatry Division Centre for Addiction and Mental Health Toronto ON Canada

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acps.12960

Reference30 articles.

1. Placebo Response in Antipsychotic Clinical Trials

2. Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials

3. Modelling and simulation of placebo effect: application to drug development in schizophrenia

4. A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

5. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Placebo Effect in Psychosis: Why It Matters and How to Measure It;Biological Psychiatry Global Open Science;2023-10

2. Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM;Neuropsychiatric Disease and Treatment;2023-01

3. Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program;Molecular Autism;2022-06-11

4. Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum Disorders;JAMA Psychiatry;2019-10-01

5. The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate?;Acta Psychiatrica Scandinavica;2019-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3